CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenue:
Net revenue	$ 756,495	$ 653,293	$ 2,190,312	$ 1,752,429
Revenue, Product and Service [Extensible List]	us-gaap:HealthCarePatientServiceMember	us-gaap:HealthCarePatientServiceMember	us-gaap:HealthCarePatientServiceMember	us-gaap:HealthCarePatientServiceMember
Costs and expenses:
Cost of net revenue	$ 646,714	$ 529,887	$ 1,853,847	$ 1,417,305
Cost, Product and Service [Extensible List]	us-gaap:HealthCarePatientServiceMember	us-gaap:HealthCarePatientServiceMember	us-gaap:HealthCarePatientServiceMember	us-gaap:HealthCarePatientServiceMember
General and administrative expenses	$ 40,681	$ 33,006	$ 124,673	$ 132,584
Depreciation and amortization, excluding patient equipment depreciation	16,151	14,690	48,113	46,014
Total costs and expenses	703,546	577,583	2,026,633	1,595,903
Operating income	52,949	75,710	163,679	156,526
Interest expense, net	28,521	24,252	78,905	69,584
Change in fair value of warrant liability (note 10)	1,364	(16,737)	(17,145)	(57,359)
Change in fair value of contingent consideration common shares liability (note 10)		(10,006)		(34,050)
Loss on extinguishment of debt		8,240		20,189
Other loss (income), net	257	(452)	7,179	698
Income before income taxes	22,807	70,413	94,740	157,464
Income tax expense	5,580	12,147	20,036	22,782
Net income	17,227	58,266	74,704	134,682
Income attributable to noncontrolling interest	1,105	174	2,800	1,449
Net income attributable to AdaptHealth Corp.	$ 16,122	$ 58,092	$ 71,904	$ 133,233
Weighted average common shares outstanding
Weighted average common shares outstanding - basic	134,227	131,684	134,186	124,228
Weighted average common shares outstanding - diluted	137,583	140,322	138,599	133,638
Net income per common share
Basic net income per share	$ 0.11	$ 0.40	$ 0.49	$ 0.97
Diluted net income per share	$ 0.11	$ 0.20	$ 0.35	$ 0.27